Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in south korea: Risk factors and clinical outcomes

Microbial Drug Resistance

Volumn 17, Issue 4, 2011, Pages 537-544

  Park, Sun Hee ^a   Choi, Su Mi ^a   Lee, Dong Gun ^a   Kim, Jayoung ^b   Choi, Jung Hyun ^a   Kim, Si Hyun ^a   Kwon, Jae Cheol ^a   Yoo, Jin Hong ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; BACTEREMIA; CLINICAL FEATURE; COMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE SEPSIS; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MORTALITY; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPTIC SHOCK; SOUTH KOREA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CONFIDENCE INTERVALS; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS;

EID: 82555191347     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0072     Document Type: Article

References (25)

1. Ben-Ami, R., M.J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, A. Leavitt, and Y. Carmeli. 2006. Influx of extended-spectrum β-lactamaseproducing Enterobacteriaceae into the hospital. Clin. Infect. Dis. 42:925-934.
2. Bone, R.C., R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, R.M. Schein, and W.J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655.
3. Charlson, M.E., P. Pompei, K.L. Ales, and C.R. MacKenzie. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
4. [CLSI] Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. fifteenth informational supplement. M100-S15. CLSI, Wayne, PA.
5. Davey, P.G., and C. Marwick. 2008. Appropriate vs. inappropriate antimicrobial therapy. Clin. Microbiol. Infect. 14 Suppl 3:15-21. (Pubitemid 351351536)
6. Friedman, N.D., K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, J.P. Briggs, W. Lamm, C. Clark, J. MacFarquhar, A.L. Walton, L.B. Reller, and D.J. Sexton. 2002. Health careassociated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797. (Pubitemid 35334450)
7. Gudiol, C., L. Calatayud, C. Garcia-Vidal, J. Lora-Tamayo, M. Cisnal, R. Duarte, M. Arnan, M. Marin, J. Carratala, and F. Gudiol. 2010. Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J. Antimicrob. Chemother. 65:333-341.
8. Harris, A.D., T.B. Karchmer, Y. Carmeli, and M.H. Samore. 2001. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin. Infect. Dis. 32:1055-1061. (Pubitemid 32299641)
9. Hooton, T.M., S.F. Bradley, D.D. Cardenas, R. Colgan, S.E. Geerlings, J.C. Rice, S. Saint, A.J. Schaeffer, P.A. Tambayh, P. Tenke, and L.E. Nicolle. 2010. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50:625-663.
10. Horan, T.C., M. Andrus, and M.A. Dudeck. 2008. CDC/ NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332. (Pubitemid 351763841)
11. Hyle, E.P., A.D. Lipworth, T.E. Zaoutis, I. Nachamkin, W.B. Bilker, and E. Lautenbach. 2005. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch. Intern. Med. 165:1375-1380. (Pubitemid 40973420)
12. Kang, C.I., S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, E.C. Kim, M.D. Oh, and K.W. Choe. 2004. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob. Agents Chemother. 48: 4574-4581.
13. Kang, C.I., J.H. Song, D.R. Chung, K.R. Peck, K.S. Ko, J.S. Yeom, H.K. Ki, J.S. Son, S.S. Lee, Y.S. Kim, S.I. Jung, S.W. Kim, H.H. Chang, S.Y. Ryu, K.T. Kwon, H. Lee, C. Moon, and S.Y. Shin. 2010. Risk factors and treatment outcomes of community-onset bacteraemia caused by extendedspectrum β-lactamase-producing Escherichia coli. Int. J. Antimicrob. Agents. 36:284-287.
14. Knaus, W.A., E.A. Draper, D.P. Wagner, and J.E. Zimmerman. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829. (Pubitemid 15250137)
15. Melzer, M., and I. Petersen. 2007. Mortality following bacteraemic infection caused by extended spectrum β-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J. Infect. 55:254-259. (Pubitemid 47244918)
16. Oteo, J., M. Perez-Vazquez, and J. Campos. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
17. Paterson, D.L., and R.A. Bonomo. 2005. Extended-spectrum β-lactamases: a clinical update. Clin.Microbiol. Rev. 18:657-686.
18. Pitout, J.D., D.B. Gregson, L. Campbell, and K.B. Laupland. 2009. Molecular characteristics of extended-spectrumb-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents. Chemother. 53:2846-2851.
19. Pitout, J.D., P. Nordmann, K.B. Laupland, and L. Poirel. 2005. Emergence of Enterobacteriaceae producing extendedspectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59. (Pubitemid 41418336)
20. Rodrguez-Bao, J., E. Picn, P. Gijn, J.R. Hernndez, M. Ruz, C. Pea, M. Almela, B. Almirante, F. Grill, J. Colomina, M. Gimnez, A. Oliver, J.P. Horcajada, G. Navarro, A. Coloma, and A. Pascual. 2010. Community-onset bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48.
21. Rodriguez-Bano, J., J.C. Alcala, J.M. Cisneros, F. Grill, A. Oliver, J.P. Horcajada, T. Tortola, B. Mirelis, G. Navarro, M. Cuenca, M. Esteve, C. Pena, A.C. Llanos, R. Canton, and A. Pascual. 2008. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch. Intern. Med. 168:1897-1902.
22. Rodriguez-Bano, J., M.D. Navarro, L. Romero, M.A. Muniain, M. Cueto, J. Galvez, E.J. Perea, and A. Pascual. 2008. Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin. Microbiol. Infect. 14:180-183.
23. Rodriguez-Bano, J., M.D. Navarro, L. Romero, M.A. Muniain, M. de Cueto, M.J. Rios, J.R. Hernandez, and A. Pascual. 2006. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin. Infect. Dis. 43:1407-1414. (Pubitemid 44845640)
24. Son, J.S., J.H. Song, K.S. Ko, J.S. Yeom, H.K. Ki, S.W. Kim, H.H. Chang, S.Y. Ryu, Y.S. Kim, S.I. Jung, S.Y. Shin, H.B. Oh, Y.S. Lee, D.R. Chung, N.Y. Lee, and K.R. Peck. 2010. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J. Korean Med. Sci. 25: 992-998.
25. Tumbarello, M., M. Sali, E.M. Trecarichi, F. Leone, M. Rossi, B. Fiori, G. de Pascale, T. D'Inzeo, M. Sanguinetti, G. Fadda, R. Cauda, and T. Spanu. 2008. Bloodstream infections caused by extended-spectrum β-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob. Agents Chemother. 52:3244-3252.